Carisma Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Carisma Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 83.54M	$ 3.80M	$ 3.60M	$ 3.24M	-
Gross Profit	$ 83.54M	$ 3.80M	$ 3.60M	$ 3.16M	-
EBIT	$ -21.47M	$ -21.43M	$ -19.75M	$ -22.88M	$ -9.43M
EBITDA	$ -19.43M	$ -19.35M	-	$ -19.56M	$ -9.44M
Net Income Common Stockholders	$ -20.97M	$ -21.43M	$ -19.88M	$ -24.46M	$ -28.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 77.61M	$ 94.14M	$ 117.08M	$ 138.97M	$ 187.92M
Total Assets	$ 89.55M	$ 106.78M	$ 133.01M	$ 156.13M	$ 189.17M
Total Debt	$ 3.12M	$ 2.75M	$ 5.23M	$ 5.47M	$ 0.00
Net Debt	$ -74.48M	$ -91.39M	$ -111.85M	$ -133.49M	$ -187.92M
Total Liabilities	$ 63.02M	$ 60.49M	$ 66.31M	$ 70.06M	$ 30.98M
Stockholders Equity	$ 26.53M	$ 46.30M	$ 66.75M	$ 86.07M	$ 158.19M
Cash Flow	-
Free Cash Flow	$ -16.66M	$ -21.19M	-	$ -25.67M	$ 2.69M
Operating Cash Flow	$ -16.10M	$ -21.00M	-	$ -25.53M	$ 2.69M
Investing Cash Flow	$ 10.44M	$ 29.81M	-	$ -3.60M	$ 59.76M
Financing Cash Flow	$ 101.00K	$ -2.03M	-	$ 67.74M	$ 1.00K

Currency in USD

Carisma Therapeutics Earnings and Revenue History

Income Statement >

Carisma Therapeutics Debt to Assets

Balance Sheet >

Carisma Therapeutics Cash Flow

Cash Flow >

Carisma Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing